DNAnexus and Sutter Health have partnered with the University of Pittsburgh Medical Center (UPMC) to launch a clinico-genomic study aimed at improving personalised therapy for multiple sclerosis (MS) patients.
Date:2019-04-24 Views:453
DNAnexus and Sutter Health have partnered with the University of Pittsburgh Medical Center (UPMC) to launch a clinico-genomic study aimed at improving personalised therapy for multiple sclerosis (MS) patients.
